MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.

Blood Cancer J · 2017 · PMC5549255 · PMID 28731457

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

The levels of PU.1 that is a validated target of the miR-155 were at borderline significance, for details see Supplementary Material 3 .

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.